Journal
DRUG DISCOVERY TODAY
Volume 24, Issue 3, Pages 845-857Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2019.01.003
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [81603209]
- 12th Six Talent Peaks Project in Jiangsu Province [2015-WSN-111]
Ask authors/readers for more resources
Drug-drug interactions (DDIs) between direct-acting antiviral (DAA) medications and acid-reducing agents mediated by gastric acid represent an important issue in drug development and treatment, which could lead to impaired bioavailability and subtherapeutic plasma concentrations of DAA drugs and subsequently compromised treatment outcomes. However, identification of clinically relevant drug interactions associated with elevated gastric pH is not well characterized. Here, we present the first comprehensive analysis of the gastric-acid-mediated drug interactions with all novel DAA medications by analyzing and revisiting in vitro data, prospective DDI trials and retrospective assessments based upon Phase II and III studies, aiming toward an in-depth understanding of the clinical implications and mitigation strategies to circumvent such interactions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available